DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Response to Amendment
In response to the Amendment received on 8/24/2026, the examiner has carefully considered the amendments. The claim rejection under 35 U.S.C. § 112, 2nd paragraph for claims 1-25 have been overcome by the amendment and has hereby been withdrawn for consideration.
Response to Arguments
Applicant's arguments filed 08/24/2026 have been fully considered but they are not persuasive. Applicant argues the teachings of Czech does not set forth the instantly claimed invention.
Applicant points to the teachings of Czech which sets forth the “solvent-borne acrylic PSA were synthesized in ethyl acetate with 50 wt.% polymer content, 2 h dosage time of monomers mixture, and 5 h post-reaction time in the presence of 0.1 wt.% radical starter AIBN at temperature of 78 °C (boiling point of ethyl acetate)”, which requires a heating step of 78 deg. C, which is outside of the claimed “room temperature”.
However, the examiner points applicant to page 481, section titled UV crosslinking of synthesized acrylic PSA: Czech explicitly teaches “The solvent-borne UV-crosslinkable acrylic PSA containing the above illustrated photoinitiators were coated directly with 60 g/m2 on a polyester film and after drying for 10 min at 105 °C crosslinked 20 s by use of an UV excimer-laser…with a wavelength of 351 nm…”. It is deemed the acrylic PSA obtained from the synthesis, as argued by applicant, inherently contains monomeric components, the acrylic copolymer comprising said photoinitiator groups corresponds to applicant’s photoinitiator; and it is deemed said radiation-cured PSAs inherently comprises a cure gradient since the radiation exposure is from the top (non-transparent substrate). The intensity of light decays exponentially as it travels deeper through the film's thickness. Additionally, Czech sets forth copolymers comprising the highest values of peel adhesion were observed for 0.3 wt.% of ABP and the excellent high cohesion were observed at concentration of about 0.1 wt.% of ABP. 0.3 wt.% of ABP quarantines have low acceptable shrinkage of 0.3 mm—i.e., determining PI concentration for tailorable residual curing stress—see Conclusion section. Therefore, the rejection still stands.
Note, claim 6, 12, 17-18 and 24 will be added to the rejection for the following reasons: It is deemed claims 6 and 24 are inherent to the radiation cured PSA set forth by Czech since this it is known, “to minimize free energy, uncured monomers diffuse upward into the highly crosslinked region, wherein this type of mass transport is generally described by Fick’s laws of diffusion, governed by local concentration gradients and network free volume. Regarding claim 12, Czech sets forth the highest values of peel adhesion were observed for 0.3 wt.% of ABP and the excellent high cohesion were observed at concentration of about 0.1 wt.% of ABP. 0.3 wt.% of ABP quarantines have low acceptable shrinkage of 0.3 mm—see conclusion section. Regarding claims 17-18: The acrylic PSAs are filler-free and the photoinitiators comprise unsaturated copolymerizable benzophenones and benzoins.
Claim Rejections - 35 USC § 102/Claim Rejections - 35 USC § 103
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
Claim(s) 1-2, 6-8, 10-12, 17-20 and 24-25 is/are rejected under 35 U.S.C. 102(a1) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over Czech et al (Polym. Bull. 2013).
Czech sets forth UV-initiated crosslinking of photoreactive acrylic pressure sensitive adhesive using excimer laser. Czech sets forth investigating the properties, such as tack, peel adhesion, shear strength, and shrinkage of self-adhesive polymer layers using UV excimer-laser and UV-lamps as UV sources. Czech sets forth it is known the performance, such as tack, peel adhesion, shear strength, and shrinkage of photoreactive acrylic adhesives are to a degree determined by photoinitiator type and concentration and by UV-crosslinking process—see page 480, 3rd full paragraph.
Czech sets forth preparing a series of photoreactive acrylic pressure sensitive adhesives in ethyl acetate of a monomer mixtures comprising between 93.0 and 94.9 wt. % of 2-ethylhexyl acrylate (corresponding to claimed monomer), 5 wt. % of acrylic acid (corresponding to applicant’s claimed monomer) and between 0.1 and 2.0 wt. % (exactly 0.1, 0.3, 0.5, 1, 1.5 and 2 wt.%) of unsaturated copolymerizable photoinitiators, ABP; ACCP, and BA (copolymerizable hydrogen abstraction type photoinitiators, see table 1) with 0.1 wt. % AIBN under thermal conditions to obtain 50 wt. % of polymeric PSA content (considered to correspond to applicant’s curing). Said polymeric PSA is then UV crosslinked by coating said photoreactive PSAs onto a polyester film or silicone paper than transferred to a PVC, drying and exposing for 20 seconds with an UV excimer-laser having a wavelength of 315 nm (see table on pate 482) and 20 sec using a conventional UV lamp to obtained a crosslinked PSA (considered to read on applicant post-curing technique).
Czech subsequently evaluated said crosslinked adhesives for tack, peel adhesion, shear strength, and shrinkage. Czech observed that tack is sensitive to variations of crosslinking time and variations of photoinitiator concentration. It was notices tack decreased with increase of yielded free radicals, wherein the largest tack drop was observed with small photoinitiator concentrations of photoinitiator ABP and the best tack was observed with the use of copolymerizable photoinitiator ABP—see figure 2. Regarding the peel adhesion, it was observed the best peel adhesion was obtained in sample exposed with UV-excimer lamp sources—see figure 3. Regarding shear strength the best observation were seen in all PSAs that were exposed/crosslinked using UV-excimer lamps when compared with those exposed/crosslinked with conventional UV lamps—see figure 5. It was additionally observed the incorporation of copolymerizable photoinitiators strongly influenced the shear strength properties of the crosslinked adhesives after exposure with the UV-lamp—see figure 5. After UV exposure an increase of the concentration of the copolymerizable photoinitiators produced higher network density, thus leading to higher cohesion when compared with convention photoinitiators, i.e. non-copolymerizable photoinitiators—see figure 6. Regarding the shrinkage, it was observed that all tested copolymerizable photoinitiators tended to generate the overall best shrinkage resistance which suggests continued crosslinking when using UV excimer lamps. It was, also, seen the best copolymerizable photoinitiator that offered higher shrinkage resistance as the photoinitiator ABP-see paragraph on page 486 and figures 7 and 8.
Czech relates to claims 1 and 19 since Czech teaches stress and strength can be tailored by selecting a copolymerizable photoinitiator and crosslinking monomeric/pre-polymeric containing compositions by exposure with a UV excimer laser vs. convention UV-curing lamps.
Regarding claim 2 and 19-20: Czech sets forth during shrinkage testing the UV crosslinked PSAs (curing technique UV) after holding for 4 weeks at a temperature of 60 deg. C (post-thermal curing technique)—see page 483, 2nd full paragraph.
Regarding claims 7, 10 and 25: Czech sets forth using copolymerizable photoinitiators in concentrations from between 0.1 to 2.0 wt. %--see page 481, paragraph under table 1.
Regarding claim 8 and 19: The compositions comprise no filler content—see experimental section.
Regarding claim 11: Said PSAs are obtained from acrylic monomers, acrylic acid and ethylhexyl acrylate.
While Czech does not expressly set forth the steps as found in the instant claims, Czech does shows strength vs. stress is enabled through crosslink density which is controlled, at least in part, by the photoinitiator type and the exposure type is known. Thusly, a skilled artisan concerned with tailoring the stress vs the strength or stress and strength balance of an adhesive can be obtained by photoinitiator choice, such as copolymerizable photoinitiators vs conventional photoinitiators, as well as, the type of energy used for exposure/crosslinking of said adhesive, i.e., UV excimer lasers vs conventional UV lamps is obvious in absence of evidence to the contrary and/or unexpected results.
Allowable Subject Matter
Claims 3-5, 9, 13-16, and 21-23 are objected to as being dependent upon a rejected base claim but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims.
Conclusion
Applicants’ amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. JPH08507094 sets forth gamma radiation post cure in photopolymerized resin compositions increases hardness. Lu et al (10,780,206) adds a polymerization inhibitor (TEMPO) to the initiator system to help reduce polymerization stress via nitroxide-mediated polymerization. Bowman et al (9,758,597) sets forth reducing polymerization induced shrinkage stress by reversible addition-fragmentation chain transfer. Lee et al (J. Mater. Res, 2001) sets forth photoinitiator concentration and exposure dosage effect the cure depth photocurable materials.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to SANZA L MCCLENDON whose telephone number is (571)272-1074. The examiner can normally be reached 8-5.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Riviere-Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/SANZA L. McCLENDON/Primary Examiner, Art Unit 1765
SMc